Keros Therapeutics Inc (KROS): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 19,833 US Dollar | 4 | 0 | 3 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 19.827.188 | 6,59 | 5,91 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Keros Therapeutics Inc
Mitarbeiter 92
Handelsplatz NASDAQ
Ticker Symbol KROS
IPO Datum 2020-04-08
Adresse 1050 Waltham Street, Lexington, MA, United States, 02421
Webseite https://www.kerostx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Jasbir S. Seehra Ph.D. | President, CEO & Director |
| 2 | Ms. Esther Cho J.D. | Chief Legal Officer & Secretary |
| 3 | Ms. Annita Tanini | VP of Finance, Corporate Controller and Interim Principal Financial & Accounting Officer |
| 4 | Justin Frantz | Head of Investor Relations |
| 5 | Dr. Lorena Lerner Ph.D. | Chief Scientific Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Nantahala Capital Management, LLC | 14,23% | 32,75 Mio. USD |
| 2 | BlackRock Inc | 14,09% | 32,44 Mio. USD |
| 3 | AQR Capital Management LLC | 4,88% | 11,24 Mio. USD |
| 4 | Vanguard Capital Management, LLC | 4,20% | 9,68 Mio. USD |
| 5 | Orbimed Advisors LLC | 3,83% | 8,81 Mio. USD |
| 6 | Federated Hermes Inc | 3,53% | 8,13 Mio. USD |
| 7 | Vanguard Portfolio Management, LLC | 3,29% | 7,58 Mio. USD |
| 8 | Mackenzie Investments | 3,17% | 7,30 Mio. USD |
| 9 | Madison Avenue Partners, LP | 3,16% | 7,28 Mio. USD |
| 10 | Qube Research & Technologies | 3,07% | 7,07 Mio. USD |
| 11 | Jacobs Levy Equity Management, Inc. | 3,05% | 7,03 Mio. USD |
| 12 | State Street Corp | 2,73% | 6,28 Mio. USD |
| 13 | Geode Capital Management, LLC | 2,58% | 5,93 Mio. USD |
| 14 | Dimensional Fund Advisors, Inc. | 2,32% | 5,35 Mio. USD |
| 15 | Citadel Advisors Llc | 2,00% | 4,60 Mio. USD |
| 16 | Renaissance Technologies Corp | 1,81% | 4,17 Mio. USD |
| 17 | D. E. Shaw & Co LP | 1,35% | 3,11 Mio. USD |
| 18 | Bridgeway Capital Management, LLC | 1,34% | 3,08 Mio. USD |
| 19 | Nuveen, LLC | 1,25% | 2,88 Mio. USD |
| 20 | ADAR1 Capital Management LLC | 1,24% | 2,87 Mio. USD |